Literature DB >> 15613296

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Miranda Z Smith1, C Jane Dale, Robert De Rose, Ivan Stratov, Caroline S Fernandez, Andrew G Brooks, Jason Weinfurter, Kendall Krebs, Cara Riek, David I Watkins, David H O'connor, Stephen J Kent.   

Abstract

Successful human immunodeficiency virus (HIV) vaccines will need to induce effective T-cell immunity. We studied immunodominant simian immunodeficiency virus (SIV) Gag-specific T-cell responses and their restricting major histocompatibility complex (MHC) class I alleles in pigtail macaques (Macaca nemestrina), an increasingly common primate model for the study of HIV infection of humans. CD8+ T-cell responses to an SIV epitope, Gag164-172KP9, were present in at least 15 of 36 outbred pigtail macaques. The immunodominant KP9-specific response accounted for the majority (mean, 63%) of the SIV Gag response. Sequencing from six macaques identified 7 new Mane-A and 13 new Mane-B MHC class I alleles. One new allele, Mane-A*10, was common to four macaques that responded to the KP9 epitope. We adapted reference strand-mediated conformational analysis (RSCA) to MHC class I genotype M. nemestrina. Mane-A*10 was detected in macaques presenting KP9 studied by RSCA but was absent from non-KP9-presenting macaques. Expressed on class I-deficient cells, Mane-A*10, but not other pigtail macaque MHC class I molecules, efficiently presented KP9 to responder T cells, confirming that Mane-A*10 restricts the KP9 epitope. Importantly, naive pigtail macaques infected with SIVmac251 that respond to KP9 had significantly reduced plasma SIV viral levels (log10 0.87 copies/ml; P=0.025) compared to those of macaques not responding to KP9. The identification of this common M. nemestrina MHC class I allele restricting a functionally important immunodominant SIV Gag epitope establishes a basis for studying CD8+ T-cell responses against AIDS in an important, widely available nonhuman primate species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613296      PMCID: PMC538543          DOI: 10.1128/JVI.79.2.684-695.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  HLA-B typing by reference strand mediated conformation analysis using a capillary-based semiautomated genetic analyzer.

Authors:  D Turner; S Akpe; J Brown; C Brown; A McWhinnie; A Madrigal; C Navarrete
Journal:  Hum Immunol       Date:  2001-04       Impact factor: 2.850

Review 2.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

3.  Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

Authors:  H T Maecker; H S Dunn; M A Suni; E Khatamzas; C J Pitcher; T Bunde; N Persaud; W Trigona; T M Fu; E Sinclair; B M Bredt; J M McCune; V C Maino; F Kern; L J Picker
Journal:  J Immunol Methods       Date:  2001-09-01       Impact factor: 2.303

4.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

5.  Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge.

Authors:  Thorsten U Vogel; Brigitte E Beer; Jan Zur Megede; Hans-Georg Ihlenfeldt; Günther Jung; Silke Holzammer; David I Watkins; John D Altman; Reinhard Kurth; Stephen Norley
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

6.  Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.

Authors:  Bianca R Mothé; Helen Horton; Donald K Carter; Todd M Allen; Max E Liebl; Pam Skinner; Thorsten U Vogel; Sarah Fuenger; Kathy Vielhuber; William Rehrauer; Nancy Wilson; Genoveffa Franchini; John D Altman; Ashley Haase; Louis J Picker; David B Allison; David I Watkins
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.

Authors:  M W Cho; Y B Kim; M K Lee; K C Gupta; W Ross; R Plishka; A Buckler-White; T Igarashi; T Theodore; R Byrum; C Kemp; D C Montefiori; M A Martin
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Vaccination with attenuated simian immunodeficiency virus by DNA inoculation.

Authors:  S J Kent; C J Dale; S Preiss; J Mills; D Campagna; D F Purcell
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.

Authors:  R Pal; D Venzon; N L Letvin; S Santra; D C Montefiori; N R Miller; E Tryniszewska; M G Lewis; T C VanCott; V Hirsch; R Woodward; A Gibson; M Grace; E Dobratz; P D Markham; Z Hel; J Nacsa; M Klein; J Tartaglia; G Franchini
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

10.  CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.

Authors:  T M Allen; B R Mothé; J Sidney; P Jing; J L Dzuris; M E Liebl; T U Vogel; D H O'Connor; X Wang; M C Wussow; J A Thomson; J D Altman; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

View more
  38 in total

1.  Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.

Authors:  Melisa L Budde; Jennifer J Lhost; Benjamin J Burwitz; Ericka A Becker; Charles M Burns; Shelby L O'Connor; Julie A Karl; Roger W Wiseman; Benjamin N Bimber; Guang Lan Zhang; William Hildebrand; Vladimir Brusic; David H O'Connor
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082:01 (Mane A*0301).

Authors:  Carrie Moore; John Sidney; A Michelle English; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Scott Southwood; Kate Bradley; Bernard A P Lafont; Bianca R Mothé; Alessandro Sette
Journal:  Immunogenetics       Date:  2012-01-26       Impact factor: 2.846

3.  Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.

Authors:  Caroline S Fernandez; Ivan Stratov; Robert De Rose; Katrina Walsh; C Jane Dale; Miranda Z Smith; Michael B Agy; Shiu-Lok Hu; Kendall Krebs; David I Watkins; David H O'connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species.

Authors:  Bernard A P Lafont; Christopher M McGraw; Sabriya A Stukes; Alicia Buckler-White; Ronald J Plishka; Russell A Byrum; Vanessa M Hirsch; Malcolm A Martin
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

5.  Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.

Authors:  Caroline S Fernandez; Miranda Z Smith; C Jane Batten; Robert De Rose; Jeanette C Reece; Erik Rollman; Vanessa Venturi; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

6.  In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.

Authors:  Liyen Loh; C Jane Batten; Janka Petravic; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

Review 7.  Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

Authors:  Sarah E Beck; Suzanne E Queen; Kenneth W Witwer; Kelly A Metcalf Pate; Lisa M Mangus; Lucio Gama; Robert J Adams; Janice E Clements; M Christine Zink; Joseph L Mankowski
Journal:  Eur J Pharmacol       Date:  2015-03-24       Impact factor: 4.432

8.  Identification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencing.

Authors:  Claire E O'Leary; Roger W Wiseman; Julie A Karl; Benjamin N Bimber; Simon M Lank; Jennifer J Tuscher; David H O'Connor
Journal:  Immunogenetics       Date:  2009-09-24       Impact factor: 2.846

9.  Peripheral NKT cells in simian immunodeficiency virus-infected macaques.

Authors:  Caroline S Fernandez; Angela C Chan; Konstantinos Kyparissoudis; Robert De Rose; Dale I Godfrey; Stephen J Kent
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

10.  Timing of immune escape linked to success or failure of vaccination.

Authors:  Jeanette C Reece; Liyen Loh; Sheilajen Alcantara; Caroline S Fernandez; John Stambas; Amy Sexton; Robert De Rose; Janka Petravic; Miles P Davenport; Stephen J Kent
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.